Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Mohammed Amir Husain, Benoît Laurent, Mélanie Plourde
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 213

Showing 1-25 of 213 citing articles:

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 214
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 173
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 135
Insulin action in the brain: cell types, circuits, and diseases
Wenqiang Chen, Weikang Cai, Benjamin Hoover, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 384-400
Open Access | Times Cited: 87
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Iris E. Jansen, Sven J. van der Lee, Duber Gomez‐Fonseca, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 821-842
Open Access | Times Cited: 78
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention
Steven Jett, Niharika Malviya, Eva Schelbaum, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 75
Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
Mariana Pires, A. Cristina Rego
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 778-778
Open Access | Times Cited: 53
Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 25
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Renqing Zhao
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Phytoconstituents as modulators of NF-κB signalling: Investigating therapeutic potential for diabetic wound healing
Jagat Pal Yadav, Amita Verma, Prateek Pathak, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117058-117058
Open Access | Times Cited: 17
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Janusz Błasiak, Piotr Sobczuk, Elżbieta Pawłowska, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101735-101735
Open Access | Times Cited: 42
The landscape of metabolic brain alterations in Alzheimer's disease
Richa Batra, Matthias Arnold, Maria A. Wörheide, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 980-998
Open Access | Times Cited: 41
ABC transporters: human disease and pharmacotherapeutic potential
Jonathan M. Moore, Eric L. Bell, Robert Hughes, et al.
Trends in Molecular Medicine (2022) Vol. 29, Iss. 2, pp. 152-172
Open Access | Times Cited: 41
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association
Larry B. Goldstein, Peter P. Tóth, Jennifer L. Dearborn, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 38
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
Fang-Ying Chiu, Yun Yen
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Pathophysiology of sarcopenia: Genetic factors and their interplay with environmental factors
Muhammad Arif Aslam, Eun Bi, Joo Young Huh
Metabolism (2023) Vol. 149, pp. 155711-155711
Closed Access | Times Cited: 25
Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8
Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review
Mohammad Banazadeh, Ardavan Abiri, Mohammad Mahdi Poortaheri, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130413-130413
Closed Access | Times Cited: 8
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 8
Dynamics of cognitive variability with age and its genetic underpinning in NIHR BioResource Genes and Cognition cohort participants
Md Shafiqur Rahman, Emma Harrison, Heather Biggs, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1739-1748
Open Access | Times Cited: 7
Cholesterol imbalance and neurotransmission defects in neurodegeneration
Kyung Chul Shin, Houda Yasmine Ali Moussa, Yongsoo Park
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 8, pp. 1685-1690
Open Access | Times Cited: 7
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Liene Bossaerts, Rita Cacace, Christine Van Broeckhoven
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 36
The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Sebastiano Giallongo, Lucia Longhitano, Simona Denaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15218-15218
Open Access | Times Cited: 33
The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis
Xiaojing Bai, Meiting Mai, Kai Yao, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top